Advertisement

 

 

T-cell receptor transfer for boosting HIV-1-specific T-cell immunity in HIV-1-infected patients.

T-cell receptor transfer for boosting HIV-1-specific T-cell immunity in HIV-1-infected patients.
Author Information (click to view)

Mummert C, Hofmann C, Hückelhoven AG, Bergmann S, Mueller-Schmucker SM, Harrer EG, Dörrie J, Schaft N, Harrer T,


Mummert C, Hofmann C, Hückelhoven AG, Bergmann S, Mueller-Schmucker SM, Harrer EG, Dörrie J, Schaft N, Harrer T, (click to view)

Mummert C, Hofmann C, Hückelhoven AG, Bergmann S, Mueller-Schmucker SM, Harrer EG, Dörrie J, Schaft N, Harrer T,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

AIDS (London, England) 30(14) 2149-58 doi 10.1097/QAD.0000000000001176

Abstract
OBJECTIVES
Strategies to cure HIV-1 infection require the eradication of viral reservoirs. An innovative approach for boosting the cytotoxic T-lymphocyte response is the transfer of T-cell receptors (TCRs). Previously, we have shown that electroporation of TCR-encoding mRNA is able to reprogram CD8 T cells derived from healthy donors. So far, it is unknown whether the transfer of HIV-1-specific TCRs is capable to reprogram CD8 T cells of HIV-1-infected patients. To assess the efficiency of TCR-transfer by mRNA electroporation and the functionality of reprogramed T cells in HIV-1-infected patients, we performed an in-vitro analysis of TCR-transfer into T cells from HIV-1-infected patients in various stages of disease and from healthy controls.

METHODS
Peripheral blood mononuclear cells from 16 HIV-1-infected patients (nine HLA-A02-positive, seven HLA-A02-negative) and from five healthy controls were electroporated with mRNA-constructs encoding TCRs specific for the HLA-A02/HIV-1-gag p17 epitope SLYNTVATL (SL9). Functionality of the TCRs was measured by γIFN-ELISpot assays.

RESULTS
SL9/TCR transfection into peripheral blood mononuclear cells from both HLA-A02-positive and HLA-A02-negative HIV-1-infected patients and from healthy blood donors reprogramed T cells for recognition of SL9-presenting HLA-A02-positive cells in γIFN-ELISpot assays. SL9/TCR-transfer into T cells from an immunodeficient AIDS patient could induce recognition of SL9-expressing target cells only after reversion of T-cell dysfunction by antiretroviral therapy.

CONCLUSION
The transfer of HIV-1-p17-specific TCRs into T cells is functional both in HIV-1-infected patients as well as in healthy blood donors. TCR-transfer is a promising method to boost the immune system against HIV-1.

Submit a Comment

Your email address will not be published. Required fields are marked *

10 − one =

[ HIDE/SHOW ]